Higo N - Search Results

1

Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34).

Suzuki Y, Nagase Y, Iga K, Kawase M, Oka M, Yanai S, Matsumoto Y, Nakagawa S, Fukuda T, Adachi H, Higo N, Ogawa Y. Suzuki Y, et al. Among authors: higo n. J Pharm Sci. 2002 Feb;91(2):350-61. doi: 10.1002/jps.10019. J Pharm Sci. 2002. PMID: 11835195

2

Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34).

Suzuki Y, Iga K, Yanai S, Matsumoto Y, Kawase M, Fukuda T, Adachi H, Higo N, Ogawa Y. Suzuki Y, et al. Among authors: higo n. J Pharm Pharmacol. 2001 Sep;53(9):1227-34. doi: 10.1211/0022357011776676. J Pharm Pharmacol. 2001. PMID: 11578105

3

Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats.

Nakamura K, Katagai K, Mori K, Higo N, Sato S, Yamamoto K. Nakamura K, et al. Among authors: higo n. Int J Pharm. 2001 May 7;218(1-2):93-102. doi: 10.1016/s0378-5173(01)00615-9. Int J Pharm. 2001. PMID: 11337153

4

[Recent trend of transdermal drug delivery system development].

Higo N. Higo N. Yakugaku Zasshi. 2007 Apr;127(4):655-62. doi: 10.1248/yakushi.127.655. Yakugaku Zasshi. 2007. PMID: 17409694 Free article. Review. Japanese.

5

Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin.

Tokumoto S, Higo N, Sugibayashi K. Tokumoto S, et al. Among authors: higo n. Int J Pharm. 2006 Dec 1;326(1-2):13-9. doi: 10.1016/j.ijpharm.2006.07.002. Epub 2006 Jul 8. Int J Pharm. 2006. PMID: 16920293

6

Design and feasibility assessment of topically applied drug formulations for electroporation.

Mori K, Tokumoto S, Kubo H, Higo N, Nozawa I, Sato S, Sugibayashi K. Mori K, et al. Among authors: higo n. Chem Pharm Bull (Tokyo). 2003 Jun;51(6):617-9. doi: 10.1248/cpb.51.617. Chem Pharm Bull (Tokyo). 2003. PMID: 12808234 Free article.

7

Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects.

Takeshi M, Ebihara T, Maekawa K, Yamamoto K, Higo N. Takeshi M, et al. Among authors: higo n. Int J Pharm. 2014 Apr 25;465(1-2):197-201. doi: 10.1016/j.ijpharm.2014.02.015. Epub 2014 Feb 12. Int J Pharm. 2014. PMID: 24530385 Clinical Trial.

8

Further evaluation of a new penetration enhancer, HPE-101.

Yano T, Higo N, Fukuda K, Tsuji M, Noda K, Otagiri M. Yano T, et al. Among authors: higo n. J Pharm Pharmacol. 1993 Sep;45(9):775-8. doi: 10.1111/j.2042-7158.1993.tb05683.x. J Pharm Pharmacol. 1993. PMID: 7903363

9

Effect of Combination of Low-Frequency Sonophoresis or Electroporation with Iontophoresis on the Mannitol Flux or Electroosmosis through Excised Skin.

Tokumoto S, Higo N, Todo H, Sugibayashi K. Tokumoto S, et al. Among authors: higo n. Biol Pharm Bull. 2016;39(7):1206-10. doi: 10.1248/bpb.b15-00696. Biol Pharm Bull. 2016. PMID: 27374295 Free article.

10

Effect of electroporation on the electroosmosis across hairless mouse skin in vitro.

Tokumoto S, Mori K, Higo N, Sugibayashi K. Tokumoto S, et al. Among authors: higo n. J Control Release. 2005 Jul 20;105(3):296-304. doi: 10.1016/j.jconrel.2005.04.002. J Control Release. 2005. PMID: 15894395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters